Affordable Access

Access to the full text

Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review

Authors
  • Ahmed, Sibtain1
  • Jafri, Lena1
  • Hoodbhoy, Zahra2
  • Siddiqui, Imran1
  • 1 Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan
  • 2 Department of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan
Type
Published Article
Journal
Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine
Publisher
Jaypee Brothers Medical Publishers
Publication Date
Jan 01, 2021
Volume
25
Issue
1
Pages
77–84
Identifiers
DOI: 10.5005/jp-journals-10071-23706
PMID: 33603306
PMCID: PMC7874291
Source
PubMed Central
Keywords
License
Green

Abstract

Background This study is aimed at reviewing the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases. Data retrieval We systematically reviewed the literature available on PubMed, MEDLINE, LitCovid NLM, and WHO: to assess the utility of PCT in prognosis of coronavirus disease. Scrutiny for eligible studies comprising articles that have evaluated the prognostic utility of PCT and data compilation was undertaken by two separate investigators. Original articles in human subjects reporting the prognostic role of PCT in adult COVID-19 patients were included. The Quality in Prognosis Studies (QUIPS) tool was utilized to assess the strength of evidence. Results were reported as narrative syntheses. Results Out of the total 426 citations, 52 articles passed through screening. The quality of evidence and methodology of included studies was overall acceptable. The total sample size of the studies comprised of 15,296 COVID-19-positive subjects. Majority of the studies were from China, i.e., 40 (77%). The PCT cut-off utilized was 0.05 ng/mL by 18 (35%) studies, followed by 0.5 ng/mL by 9 (17.5%). Eighty five percent ( n = 44) studies reported statistically significant association ( p value < 0.05) between PCT and severity. Conclusion Procalcitonin appears as a promising prognostic biomarker of COVID-19 progression in conjunction with the clinical context. How to cite this article Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med 2021;25(1):77–84.

Report this publication

Statistics

Seen <100 times